Skip to main content
Top
Published in: Archives of Virology 10/2008

01-10-2008 | Original Article

Effect of two synthetic peptides mimicking conserved regions of equine infectious anemia virus proteins gp90 and gp45 upon cytokine mRNA expression

Authors: Alejandra S. Bailat, Adriana R. Soutullo, María I. García, Carolina M. Veaute, Lucila Garcia, Andrea L. Racca, Ileana S. Malan Borel

Published in: Archives of Virology | Issue 10/2008

Login to get access

Abstract

Gp90 and gp45 synthetic peptides, which mimic conserved sequences of native viral proteins, are recognized by antibodies to equine infectious anemia virus (EIAV) in asymptomatic carrier horses and generate humoral and cellular responses in immunized mice. Cytokine mRNA levels were evaluated in equine peripheral blood mononuclear cells (PBMCs) after in vitro stimulation with gp90 and gp45 with the aim of determining the cytokine profile associated with the proliferative response. Stimulation index (SI) values indicate that 100 and 60% of EIAV-infected horses recognized gp90 and gp45, respectively. A strong positive correlation was found between IL-12p40 and SI, IFN-γ and SI, and IL-12p40 and IFN-γ (p < 0.001). These results suggest the presence of specific memory cells that would contribute to maintain reinfection resistance and that conserved viral regions represented by gp90 and gp45 synthetic peptides may be good candidates for inclusion in vaccine strategies against EIAV.
Literature
1.
go back to reference Gonda MA, Charman HP, Walker JL, Coggins L (1978) Scanning and transmission electron microscopic study of equine infectious anemia virus. Am J Vet Res 39:731–740PubMed Gonda MA, Charman HP, Walker JL, Coggins L (1978) Scanning and transmission electron microscopic study of equine infectious anemia virus. Am J Vet Res 39:731–740PubMed
2.
go back to reference Cheevers WP, McGuire TC (1985) Equine infectious anemia virus: immunopathogenesis and persistence. Rev Infect Dis 7:83–88PubMed Cheevers WP, McGuire TC (1985) Equine infectious anemia virus: immunopathogenesis and persistence. Rev Infect Dis 7:83–88PubMed
3.
go back to reference Hammond SA, Cook SJ, Lichtenstein DI, Issel CJ, Montelaro RC (1997) Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J Virol 71:3840–3852PubMed Hammond SA, Cook SJ, Lichtenstein DI, Issel CJ, Montelaro RC (1997) Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J Virol 71:3840–3852PubMed
4.
go back to reference McGuire TC, Leib SR, Lonning SM, Zhang W, Byme KM, Mealey RH (2000) Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses. J Gen Virol 81:735–739 McGuire TC, Leib SR, Lonning SM, Zhang W, Byme KM, Mealey RH (2000) Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses. J Gen Virol 81:735–739
5.
go back to reference Fraser DG, Oaks JL, Brown WC, McGuire TC (2002) Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus. Immunology 105:295–305PubMedCrossRef Fraser DG, Oaks JL, Brown WC, McGuire TC (2002) Identification of broadly recognized, T helper 1 lymphocyte epitopes in an equine lentivirus. Immunology 105:295–305PubMedCrossRef
6.
go back to reference Kono Y, Hirasawa K, Fukunaga Y, Taniguchi T (1976) Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl Inst Anim Health Q (Tokyo) 16:8–15 Kono Y, Hirasawa K, Fukunaga Y, Taniguchi T (1976) Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl Inst Anim Health Q (Tokyo) 16:8–15
7.
go back to reference Montelaro RC, Ball JM, Rushlow KE (1993) Equine retroviruses. In: Levy JA (ed) The retroviridae. Plenum Press, New York, pp 257–360 Montelaro RC, Ball JM, Rushlow KE (1993) Equine retroviruses. In: Levy JA (ed) The retroviridae. Plenum Press, New York, pp 257–360
8.
go back to reference Hussain KA, Issel CJ, Schnorr KL, Rwambo PM, West M, Montelaro RC (1988) Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90. Arch Virol 98:213–224PubMedCrossRef Hussain KA, Issel CJ, Schnorr KL, Rwambo PM, West M, Montelaro RC (1988) Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90. Arch Virol 98:213–224PubMedCrossRef
9.
go back to reference Chong YH, Ball JM, Issel CJ, Montelaro RC, Rushwol KE (1991) Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus. J Virol 65:1013–1018PubMed Chong YH, Ball JM, Issel CJ, Montelaro RC, Rushwol KE (1991) Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus. J Virol 65:1013–1018PubMed
10.
go back to reference Soutullo A, Verwimp V, Riveros M, Pauli R, Tonarelli G (2001) Design and validation of an ELISA for equine infectious anemia (EIA) diagnosis using synthetic peptides. Vet Microbiol 79:111–121PubMedCrossRef Soutullo A, Verwimp V, Riveros M, Pauli R, Tonarelli G (2001) Design and validation of an ELISA for equine infectious anemia (EIA) diagnosis using synthetic peptides. Vet Microbiol 79:111–121PubMedCrossRef
11.
go back to reference Soutullo A, García MI, Bailat A, Racca A, Tonarelli G, Malan Borel I (2005) Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides. Vet Immunol Immunopathol 108:335–343PubMedCrossRef Soutullo A, García MI, Bailat A, Racca A, Tonarelli G, Malan Borel I (2005) Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides. Vet Immunol Immunopathol 108:335–343PubMedCrossRef
12.
go back to reference Pancino G, Camoin L, Sonigo P (1995) Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J Virol 69:2110–2118PubMed Pancino G, Camoin L, Sonigo P (1995) Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J Virol 69:2110–2118PubMed
13.
go back to reference Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol 14:778–809CrossRef Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol 14:778–809CrossRef
14.
go back to reference Mossman TR, Coffmann RL (1989) Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173CrossRef Mossman TR, Coffmann RL (1989) Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173CrossRef
16.
go back to reference Watford WT, Moriguchi M, Morinobu A, O’Shea JJ (2003) The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 14:361–368PubMedCrossRef Watford WT, Moriguchi M, Morinobu A, O’Shea JJ (2003) The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 14:361–368PubMedCrossRef
17.
go back to reference Atherton E, Sheppard RE (1989) Solid phase peptide synthesis: a practical approach. In: Practical approach series. IRL Press at Oxford University Press, Oxford Atherton E, Sheppard RE (1989) Solid phase peptide synthesis: a practical approach. In: Practical approach series. IRL Press at Oxford University Press, Oxford
18.
go back to reference Fields G, Noble R (1990) Solid phase peptide synthesis utilizing 9-fluorenilmetoxycarbonil aminoacids. Int J Pept Protein Res 35:161–214PubMed Fields G, Noble R (1990) Solid phase peptide synthesis utilizing 9-fluorenilmetoxycarbonil aminoacids. Int J Pept Protein Res 35:161–214PubMed
20.
go back to reference Coggins L, Norcross ML, Nusbaum SR (1972) Diagnosis of equine infectious anemia by immunodiffusion test. Am J Vet Res 33:11–18PubMed Coggins L, Norcross ML, Nusbaum SR (1972) Diagnosis of equine infectious anemia by immunodiffusion test. Am J Vet Res 33:11–18PubMed
21.
go back to reference Van den Hoven R, Duvigneau JC, Hartl RT, Riedelberger K, Teinfalt M, Gemeiner M (2004) The expression of messenger RNA for tumor necrosis factor-α; interleukins 1β, 6, 8, and 10; tissue growth factor-β; and interferon-γ in bronchoalveolar lavage fluid cells from horses challenged with lipopolysaccharide and treated with clenbuterol. J Equine Vet Sci 24:29–36CrossRef Van den Hoven R, Duvigneau JC, Hartl RT, Riedelberger K, Teinfalt M, Gemeiner M (2004) The expression of messenger RNA for tumor necrosis factor-α; interleukins 1β, 6, 8, and 10; tissue growth factor-β; and interferon-γ in bronchoalveolar lavage fluid cells from horses challenged with lipopolysaccharide and treated with clenbuterol. J Equine Vet Sci 24:29–36CrossRef
22.
go back to reference Fraser DG, Mealey RH, McGuire TC (2003) Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides. Immunogenetics 55:508–514PubMedCrossRef Fraser DG, Mealey RH, McGuire TC (2003) Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides. Immunogenetics 55:508–514PubMedCrossRef
23.
go back to reference Cheevers WP, Beyer JC, Knowles DP (1997) Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection. J Virol 71:6259–6263PubMed Cheevers WP, Beyer JC, Knowles DP (1997) Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection. J Virol 71:6259–6263PubMed
24.
go back to reference Giguère S, Prescott JF (1999) Quantitation of equine cytokine mRNA expression by reverse transcription-competitive polymerase chain reaction. Vet Immunol Immunopathol 67:1–15PubMedCrossRef Giguère S, Prescott JF (1999) Quantitation of equine cytokine mRNA expression by reverse transcription-competitive polymerase chain reaction. Vet Immunol Immunopathol 67:1–15PubMedCrossRef
25.
go back to reference Lim WS, Edwards JF, Boyd NK, Payne SL, Ball JM (2003) Simultaneous quantitation of equine cytokine mRNAs using a multi-probe ribonuclease protection assay. Vet Immunol Immunopathol 91:45–51PubMedCrossRef Lim WS, Edwards JF, Boyd NK, Payne SL, Ball JM (2003) Simultaneous quantitation of equine cytokine mRNAs using a multi-probe ribonuclease protection assay. Vet Immunol Immunopathol 91:45–51PubMedCrossRef
26.
go back to reference Kleinbaum D, Kupper L, Muller K (1988) Applied regression analysis and other multivariable methods. PWS-Kent, Boston Kleinbaum D, Kupper L, Muller K (1988) Applied regression analysis and other multivariable methods. PWS-Kent, Boston
27.
go back to reference Tagmyer TL, Craigo JK, Cook SJ, Issel CJ, Montelaro RC (2007) Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus. J Gen Virol 88:1324–1336PubMedCrossRef Tagmyer TL, Craigo JK, Cook SJ, Issel CJ, Montelaro RC (2007) Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus. J Gen Virol 88:1324–1336PubMedCrossRef
28.
go back to reference Hammond SA, Raabe ML, Issel CJ, Montelaro RC (1999) Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus. Virology 262:416–430PubMedCrossRef Hammond SA, Raabe ML, Issel CJ, Montelaro RC (1999) Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus. Virology 262:416–430PubMedCrossRef
29.
go back to reference Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK (1996) IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471–481PubMedCrossRef Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK (1996) IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471–481PubMedCrossRef
30.
go back to reference Zhang X, Wang Y, Liang H, Wei L, Xiang W, Shen R, Shao Y (2007) Correlation between the induction of Th1 cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression. J Gen Virol 88:998–1004PubMedCrossRef Zhang X, Wang Y, Liang H, Wei L, Xiang W, Shen R, Shao Y (2007) Correlation between the induction of Th1 cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression. J Gen Virol 88:998–1004PubMedCrossRef
31.
go back to reference Imami N, Pires A, Hardy G, Wilson J, Gazzard B, Gotch F (2002) A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection. J Virol 76:9011–9023PubMedCrossRef Imami N, Pires A, Hardy G, Wilson J, Gazzard B, Gotch F (2002) A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection. J Virol 76:9011–9023PubMedCrossRef
32.
go back to reference McGuire TC, Tumas DB, Byrne KM, Hines MT, Leib SR, Brassfield AL, O’Rourke KI, Perryman LE (1994) Major histocompability complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J Virol 68:1459–1467PubMed McGuire TC, Tumas DB, Byrne KM, Hines MT, Leib SR, Brassfield AL, O’Rourke KI, Perryman LE (1994) Major histocompability complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J Virol 68:1459–1467PubMed
Metadata
Title
Effect of two synthetic peptides mimicking conserved regions of equine infectious anemia virus proteins gp90 and gp45 upon cytokine mRNA expression
Authors
Alejandra S. Bailat
Adriana R. Soutullo
María I. García
Carolina M. Veaute
Lucila Garcia
Andrea L. Racca
Ileana S. Malan Borel
Publication date
01-10-2008
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 10/2008
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-008-0199-2

Other articles of this Issue 10/2008

Archives of Virology 10/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.